EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Administration of a bacterial lysate to the airway compartment is sufficient to inhibit allergen-induced lung eosinophilia in germ-free mice

Ashley N Michael, Oksana Pivniouk, Peace C Ezeh, Sunil Banskar, Seongmin Hahn, Avery DeVries, Kathryn O'Connell, Vadim Pivniouk, Donata Vercelli iD

Journal of Leukocyte Biology · 2024

DOI: 10.1093/jleuko/qiae047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2024. Verfasst von Ashley N Michael und 8 weiteren Autor:innen. Beteiligte Einrichtung: Asthma and Airway Disease Research Center, University of Arizona, 1501 N. Campbell Avenue P.O. Box 245030, Tucson, AZ 85724, United States. Hauptthemen laut MEDLINE: Allergens, Germ-Free Life. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIEHS NIH HHS, NIH HHS, University of Arizona.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The nexus between eosinophils and microbes is attracting increasing attention. We previously showed that airway administration of sterile microbial products contained in dust collected from traditional dairy farms virtually abrogated bronchoalveolar lavage (BAL) eosinophilia and other cardinal asthma phenotypes in allergen-sensitized specific pathogen–free (SPF) mice. Interestingly, comparable inhibition of allergen-induced BAL eosinophilia and promotion of airway barrier integrity were found upon administration of a sterile, pharmacological-grade bacterial lysate, OM-85, to the airway compartment of allergen-sensitized SPF mice. Here, we asked whether intrinsic properties of airway-delivered microbial products were sufficient to inhibit allergic lung inflammation or whether these effects were mediated by reprogramming of the host microbiota. We compared germ-free (GF) mice and offspring of GF mice associated with healthy mouse gut microbiota and maintained under SPF conditions for multiple generations (Ex-GF mice). These mice were treated intranasally with OM-85 and evaluated in the ovalbumin and Alternaria models of allergic asthma focusing primarily on BAL eosinophilia. Levels of allergen-induced BAL eosinophilia were comparable in GF and conventionalized Ex-GF mice. Airway administration of the OM-85 bacterial lysate was sufficient to inhibit allergen-induced lung eosinophilia in both Ex-GF and GF mice, suggesting that host microbiota are not required for the protective effects of bacterial products in these models and local airway exposure to microbial products is an effective source of protection. OM-85–dependent inhibition of BAL eosinophilia in GF mice was accompanied by suppression of lung type 2 cytokines and eosinophil-attracting chemokines, suggesting that OM-85 may work at least by decreasing eosinophil lung recruitment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AllergensGerm-Free LifeAnimalsMiceAsthmaPulmonary EosinophiliaOvalbuminFemaleBronchoalveolar Lavage FluidLungMice, Inbred BALB CCell ExtractsDisease Models, AnimalBacterial Lysates

Stichwörter der Autor:innen

eosinophiliagerm-free micelungmicrobes

Substanzen

AllergensOvalbuminBroncho-VaxomCell ExtractsBacterial Lysates

Autor:innen und Institutionen

  • Asthma and Airway Disease Research Center, University of Arizona, 1501 N. Campbell Avenue P.O. Box 245030, Tucson, AZ 85724, United States.
  • University Animal Care, University of Arizona, BIO5 Institute, 1657 E Helen Street, Tucson, AZ 85721, United States.
  • Department of Cellular and Molecular Medicine, University of Arizona, 1501 N. Campbell Avenue P.O. Box 245044, Tucson AZ 85724-5044, United States.
  • BIO5 Institute, University of Arizona, 1657 E Helen Street, Tucson, AZ 85721, United States.
  • Arizona Center for the Biology of Complex Diseases, University of Arizona, BIO5 Institute, University of Arizona, Tucson, AZ 85721, United States.

ORCID-Profile: Donata Vercelli

Förderung

  • NIEHS NIH HHS
  • NIH HHS
  • University of Arizona
  • NIAID NIH HHS
  • OM Pharma SA
  • National Institutes of Health

Zitieren

APA

Michael, A. N., Pivniouk, O., Ezeh, P. C., Banskar, S., Hahn, S., DeVries, A., O'Connell, K., Pivniouk, V., & Vercelli, D. (2024). Administration of a bacterial lysate to the airway compartment is sufficient to inhibit allergen-induced lung eosinophilia in germ-free mice. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae047

Vancouver

Michael AN, Pivniouk O, Ezeh PC, Banskar S, Hahn S, DeVries A, et al. Administration of a bacterial lysate to the airway compartment is sufficient to inhibit allergen-induced lung eosinophilia in germ-free mice. Journal of Leukocyte Biology. 2024. doi:10.1093/jleuko/qiae047

BibTeX
@article{Michael2024,
  author = {Michael, Ashley N and Pivniouk, Oksana and Ezeh, Peace C and Banskar, Sunil and Hahn, Seongmin and DeVries, Avery and O'Connell, Kathryn and Pivniouk, Vadim and Vercelli, Donata},
  title = {Administration of a bacterial lysate to the airway compartment is sufficient to inhibit allergen-induced lung eosinophilia in germ-free mice},
  journal = {Journal of Leukocyte Biology},
  year = {2024},
  doi = {10.1093/jleuko/qiae047}
}
Kostenlos starten →